xie – -Translation – Keybot Dictionary

Spacer TTN Translation Network TTN TTN Login Deutsch Français Spacer Help
Source Languages Target Languages
Keybot 32 Results  hc-sc.gc.ca
  Membres du Conseil cons...  
Dre Sherry Xueju Xie (2012-2014)
Dr. Sherry Xueju Xie (2012-2014)
  Bibliographie - Évaluat...  
Xie, Xiaodi, Lynda Robson, Eric Single, Jurgen Rehm, and Josh Paul. 1999. « The Economic Consequences of Smoking in Ontario », Pharmacological Research. Vol. 39, No. 3 : 185-191.
Xie, Xiaodi, Lynda Robson, Eric Single, Jurgen Rehm, and Josh Paul.  1999.  "The Economic Consequences of Smoking in Ontario."  Pharmacological Research.  Vol. 39, No. 3: 185-191.
  Déclarations de besoin ...  
Sherri Xie : sherri.xie@gov.ab.ca
First point of contact:
  Page 30 - Meilleures pr...  
Mueser, K.T., Sengupta, A., Schooler, N.R., Belleck, A.S., Xie, H., Glick, I.D., & Kieth, S.J. (in press). Family treatment and medication dose reduction in schizophrenia: Effects on patient social functioning, family attitudes and burden.
Mandersheid, R.W., & Rosenstein, M. J. (1992). Homeless persons with mental illness and alcohol or other drug abuse: Current research, policy, and prospects.
  Renoncement au tabac en...  
Single, E., L. Robson, X. Xie, J. Rehm et al. (1996).
. Second edition. www.endsmoking.org
  Déclarations de besoin ...  
Sherri Xie : sherri.xie@gov.ab.ca
First point of contact:
  Page 18 - Réduire les m...  
Single, E., Robson, L., Rehm, J., Xie, X. (1996b). « Morbidity and mortality attributable to substance abuse in Canada », American Journal of Public Health, 89, 385-390.
Fischer, B., Medved, W., Gliksman, L., Rehm, J. (1999). Illicit opiate users in Toronto: a profile of current users. Addiction Research, 7, 377-415.
  Page 18 - Réduire les m...  
Single, E., Robson, L., Xie, X., Rehm, J. (1998). « The economic costs of alcohol, tobacco and illicit drugs in Canada », 1992, Addiction, 93(7), 983-998.
Single, E., Robson, L., Xie, X., Rehm, J. (1998). The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction, 93(7), 983-998.
  Page 18 - Réduire les m...  
Single, E., Robson, L., Xie, X. & Rehm, J. (1998). « The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992 », Addiction, 93 (7), 983-998.
Single, E., Robson, L., Xie, X. & Rehm, J. (1998). The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction, 93 (7), 983-998.
  Page 18 - Réduire les m...  
Single, E., Robson, L., Rehm, J. et Xie, X. (1999). « Morbidity and mortality attributable to substance abuse in Canada », American Journal of Public Health, 89, 385-390.
Single, E., Robson, L., Rehm, J. & Xie, X. (1999). Morbidity and mortality attributable to substance abuse in Canada. American Journal of Public Health, 89, 385-390.
  Personnes-ressources - ...  
Mme Sherri Xie
Ms. Sherri Xie
  Page 18 - Réduire les m...  
Single, E., Robson, L., Rehm, J., Xie, X (1999b). « Morbidity and mortality attributable to substance abuse in Canada », American Journal of Public Health, 89, 385-390.
Single, E., Robson, L., Rehm, J., Xie, X (1999b). Morbidity and mortality attributable to substance abuse in Canada. American Journal of Public Health, 89, 385-390.
  Membres du Conseil cons...  
La Dre Sherry Xueju Xie, conseillère scientifique en chef et gestionnaire de la recherche et du développement chez Viva Pharmaceutical Inc. , se spécialise dans la formulation de produits de santé naturels, la mise au point de remèdes naturels à l'aide de la médecine traditionnelle chinoise et de nouveaux minéraux chélatés à biodisponibilité élevée ainsi que la conception de modèles animaux pour les essais relatifs aux remèdes naturels à base de plantes depuis sept ans.
Dr. Sherry Xueju Xie is the Chief Scientific Officer and Research and Development Manager in Viva Pharmaceutical Inc., where she has specialized in natural health products formulation, natural remedy development using Traditional Chinese Medicine, development of novel pure mineral chelates with high bioavailability, and animal model design for trial runs on natural herbal remedies over the past 7 years. She holds a Ph.D. in antioxidative and bioactive phytochemicals and nutrition from Kansas State University, USA. She was a member of the American Association of Cereal Chemists for 8 years, and she is author and co-author of numerous research papers published in peer-reviewed journals, a book chapter, and three US patents - insomnia remedy, amino acid chelates, and natural health product formulation, respectively. She also has experience with deposition and testimony in a New York court as an expert witness concerning dietary supplement in 2010 and 2012, which helped defendants win both lawsuits.
  Page 6 - Recommandation...  
Tao, L., Yan, S., Xie, M., Kramer, P.M. et Pereira, M.A. (2000b) Effect of trichloroethylene and its metabolites, dichloroacetic acid and trichloroacetic acid, on the methylation and expression of c-jun and c-myc protooncogenes in mouse liver: Prevention by methionine.
U.S. EPA (United States Environmental Protection Agency) (1999a) AIRDATA. Office of Air Quality Planning and Standards, U.S. Environmental Protection Agency, Research Triangle Park, NC.
  Page 18 - Réduire les m...  
Statistique Canada (1998). Adult Correctional Services in Canada, 1996-97. Ottawa, ON : ministre de l'Industrie, Catalogue no 85-211-XIE, ISSN 1480-8501.
Statistics Canada (1998). Adult Correctional Services in Canada, 1996-97. Ottawa, ON: Minister of Industry, Catalogue no. 85-211-XIE, ISSN 1480-8501.
  Personnes-ressources - ...  
Courriel : sherri.xie@gov.ab.ca
E-mail: sherri.xie@gov.ab.ca
  Le sélénium [Document t...  
Xu, G.-L., Hong, S.-Y., Song, H.-B. et Xie, J.-K. Keshan disease and selenium deficiency. Nutr. Res., Suppl. I: 187 (1985).
Levander, O.A. and Bauman, C.A. Selenium metabolism. VI. Effect of arsenic on the excretion of selenium in the bile. Toxicol. Appl. Pharmacol., 9: 106 (1966)
  Page 6 - Recommandation...  
Tao, L., Yang, S., Xie, M., Kramer, P.M. et Pereira, M.A. (2000a) Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors.
U.S. EPA (United States Environmental Protection Agency) (1995) The use of the benchmark dose approach in health risk assessment. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC (EPA/630/R-94/007).